Holen Sie sich die Stockscreener-App
4.95
0.20%
-0.010
Handel nachbörslich:
5.04
0.09
+1.82%
Schlusskurs vom Vortag:
$4.96
Offen:
$5.01
24-Stunden-Volumen:
5.82M
Relative Volume:
1.90
Marktkapitalisierung:
$581.67M
Einnahmen:
$2.35B
Nettoeinkommen (Verlust:
$-74.42M
KGV:
-5.266
EPS:
-0.94
Netto-Cashflow:
$150.93M
1W Leistung:
-26.34%
1M Leistung:
-37.66%
6M Leistung:
-45.30%
1J Leistung:
-62.95%
1-Tages-Spanne:
$4.90
$5.25
1-Wochen-Bereich:
$4.90
$6.89
52-Wochen-Spanne:
$4.90
$15.56
Evolent Health Inc Stock (EVH) Company Profile
Firmenname
Evolent Health Inc
Sektor
Branche
Telefon
571-389-6000
Adresse
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Vergleichen Sie EVH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
4.95 | 553.50M | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
295.75 | 48.33B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
71.78 | 12.73B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
99.83 | 8.07B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
52.54 | 10.22B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.11 | 6.93B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-03 | Bestätigt | BTIG Research | Buy |
| 2024-11-08 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | Hochstufung | Truist | Hold → Buy |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-01 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-10-16 | Eingeleitet | UBS | Buy |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2022-11-01 | Eingeleitet | Truist | Hold |
| 2022-07-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-11-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-04-29 | Fortgesetzt | JP Morgan | Neutral |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-07-06 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | Herabstufung | Goldman | Buy → Neutral |
| 2020-06-02 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | Fortgesetzt | Leerink Partners | Outperform |
| 2018-06-04 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-04-24 | Fortgesetzt | JP Morgan | Neutral |
| 2017-09-20 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2017-03-14 | Eingeleitet | Oppenheimer | Outperform |
| 2017-01-13 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | Fortgesetzt | JP Morgan | Overweight |
| 2016-08-05 | Bestätigt | FBR Capital | Outperform |
| 2016-07-26 | Eingeleitet | Jefferies | Buy |
| 2016-07-13 | Bestätigt | FBR Capital | Outperform |
| 2016-03-29 | Eingeleitet | FBR Capital | Outperform |
| 2016-01-06 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-06-30 | Eingeleitet | Goldman | Buy |
| 2015-06-30 | Eingeleitet | JP Morgan | Overweight |
| 2015-06-30 | Eingeleitet | Leerink Partners | Outperform |
| 2015-06-30 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Evolent Health Inc Aktie (EVH) Neueste Nachrichten
Evolent Health (EVH) Analyst Rating Update: Target Price Lowered by Truist Securities | EVH Stock News - GuruFocus
EVH: Analyst Constantine Davides Lowers Price Target to $11 | EV - GuruFocus
Truist Cuts Price Target on Evolent Health to $10 From $16, Keeps Buy Rating - MarketScreener
Will Evolent Health Inc. see short term momentumPortfolio Risk Summary & High Win Rate Trade Tips - newser.com
Evolent Health price target lowered to $11 from $13 at Citizens JMP - TipRanks
Citizens lowers Evolent Health stock price target to $11 on revised EBITDA - Investing.com Canada
Truist Securities lowers Evolent Health stock price target to $10 from $16 - Investing.com Canada
Why Evolent Health Inc. stock is popular among millennialsJuly 2025 Closing Moves & Free Community Supported Trade Ideas - newser.com
Is Evolent Health Inc. stock ready for a breakoutPortfolio Performance Report & Long-Term Capital Growth Strategies - newser.com
Is Evolent Health Inc. stock positioned well for digital economyDividend Hike & Accurate Entry/Exit Alerts - newser.com
Reversal indicators forming on Evolent Health Inc. stockQuarterly Profit Report & Risk Controlled Swing Alerts - newser.com
Evolent Health Inc. stock prediction for this week2025 Volatility Report & Growth-Oriented Investment Plans - newser.com
What MACD signals say about Evolent Health Inc.Oil Prices & Precise Buy Zone Identification - newser.com
Evolent Health projects $2.5B 2026 revenue with $750M in new contracts while expanding oncology partnerships - MSN
Evolent Health Inc. Reports Strong Q3 Earnings and Strategic Growth - TipRanks
Evolent Health Hits New 52-Week Low at $5.97 Amidst Major Decline - Markets Mojo
Evolent Health, Inc. (NYSE:EVH) Q3 2025 Earnings Call Transcript - Insider Monkey
Evolent Health Reports Strong Q3 2025 Results - MSN
Evolent Health (EVH) Misses Q3 Earnings Estimates - sharewise.com
Evolent Health Inc Class A (EVH) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
BTIG Maintains Evolent Health (EVH) Buy Recommendation - Nasdaq
EVH Q3 Deep Dive: Contract Wins and Industry Uncertainty Shape Outlook - Yahoo Finance
Earnings call transcript: Evolent Health Q3 2025 misses EPS, stock drops 5.5% - Investing.com Nigeria
Evolent Health Inc earnings missed by $0.06, revenue topped estimates - Investing.com Australia
What indicators show strength in Evolent Health Inc.Weekly Trend Report & Daily Chart Pattern Signals - newser.com
Evolent Health Q3 2025 slides: Revenue grows 8% sequentially amid shifting business mix - Investing.com Nigeria
Evolent Health, Inc.'s (NYSE:EVH) 26% Dip In Price Shows Sentiment Is Matching Revenues - 富途牛牛
What high frequency data says about Evolent Health Inc.Earnings Trend Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Evolent Health: Q3 Earnings Snapshot - theheraldreview.com
Can Evolent Health Inc. rally from current levels2025 Macro Impact & Free Accurate Trade Setup Notifications - newser.com
Evolent Health, Inc. SEC 10-Q Report - TradingView
Earnings call transcript: Evolent Health Q3 2025 misses EPS, stock drops 5.5% By Investing.com - Investing.com South Africa
Evolent Health Inc (EVH) Q3 2025 Earnings Call Highlights: Stron - GuruFocus
Evolent Health Inc (EVH) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market ... - Yahoo Finance
Evolent Health Beats Revenue Forecasts And Sets Sights On Growth - Finimize
Compared to Estimates, Evolent Health (EVH) Q3 Earnings: A Look at Key Metrics - sharewise.com
Risk vs reward if holding onto Evolent Health Inc.2025 Major Catalysts & Growth Oriented Trading Recommendations - newser.com
Evolent Health Inc appoints Mario Ramos as CFO effective January 1, 2026SEC filing - MarketScreener
[10-Q] Evolent Health, Inc. Quarterly Earnings Report | EVH SEC FilingForm 10-Q - Stock Titan
Evolent Health Inc Reports Q3 2025 Revenue of $479.53M, Exceedin - GuruFocus
EVH Forecasts Strong FY25 with Projected EBITDA Growth - GuruFocus
Evolent Health (NYSE:EVH) Beats Q3 Sales Expectations, Stock Jumps 14.8% - Yahoo Finance
Evolent Health Announces Leadership Changes Amid Growth - TipRanks
EVH Stock Projects Adjusted EBITDA Between $30M and $40M - GuruFocus
Finanzdaten der Evolent Health Inc-Aktie (EVH)
Umsatz
Nettogewinn
Free Cashflow
ENV
12.00%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):